(“NetScientific”, the “Group” or the “Company”)
Notice of Results
NetScientific plc (AIM: NSCI), the international life sciences and sustainability technology investment and commercialisation Group, will announce results for the year ended 31 December 2021 on Thursday 12 May.
Analyst Briefing: 09.30, Thursday 12 May
Management will be hosting a remote presentation via web conference on the day of the results at 09.30 BST. Analysts wishing to join should register their interest by emailing firstname.lastname@example.org or by telephoning 020 7933 8780.
Investor Presentation: 16.00, Thursday 12 May
The Company will be hosting a presentation to discuss the results through the digital platform, Investor Meet Company, at 16.00 on the day of the results.
Questions can be submitted pre-event to email@example.com, or in real time during the presentation, via the “Ask a Question” function. Whilst the Company may not be in a position to answer every question it receives, it will address the most prominent within the confines of information already disclosed to the market through regulatory notifications. Responses to the Q&A from the live presentation will be published at the earliest opportunity on the IMC platform.
Investors can sign up to Investor Meet Company for free and add to meet NetScientific via the following link https://www.investormeetcompany.com/netscientific-plc/register-investor
Those investors who have already registered with Investor Meet Company will automatically be invited.
A copy of the presentation will be made available on the Company’s website shortly after the presentation.
For more information, please contact:
|NetScientific||Via Walbrook PR|
|Ilian Iliev, CEO|
|WH Ireland (NOMAD, Financial Adviser and Broker)|
|Chris Fielding / Darshan Patel||+44 (0)20 7220 1666|
|Walbrook PR||+44 (0)20 7933 8780 or firstname.lastname@example.org|
|Nick Rome / Tom Cooper||07748 325 236 / 07971 221 972|
NetScientific plc (AIM: NSCI) is a holding company, that invests in, develops, commercialises and realises shareholder value in life sciences/healthcare, sustainability and technology companies, which offer significant growth potential predominately in the UK and USA, as well as globally.
With the acquisition of EMV Capital in August 2020, the Group doubled its portfolio from 8 to 17 companies, either through direct subsidiary, balance sheet investment or capital under advisory, varying from start-up private companies to publicly listed equities.
NetScientific delivers shareholder returns through a proactive and hands-on management approach to their portfolio companies; identifying, investing in, and helping to build game-changing companies. The Group targets value inflection points and the release of value through partial or full exits from trade sales, public listings, or equity sales. The Company has a strong transatlantic and growing international presence, providing attractive expansion prospects.
NSCI can deploy a capital-light investment structure; utilising the power of the PLC Brand, and the NetScientific balance sheet to anchor future investments and achieve a multiplier effect by attracting 3rd party investment for the portfolio companies.
NetScientific is headquartered in London, United Kingdom, and was admitted to trading on AIM, a market operated by the London Stock Exchange, in 2013 (website: netscientific.net).